This is a daily average of polls conducted by dozens of different organizations since Inauguration Day. See the latest polls. Inaug. About this data Note: Individual poll results are shown as circles.
13hon MSN
India approves first dengue vaccine Qdenga: Who can get it, dosage and key details explained
Dengue vaccine: India has approved its first vaccine for dengue prevention, marking a major milestone in the fight against ...
India, July 21 -- In a major step to strengthen the country's fight against dengue, the Central Drugs Standard Control ...
SK pharmteco today announced details of its ongoing strategic manufacturing partnership with Genethon, a France-based pioneering nonprofit research and development organization dedicated to gene ...
India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...
Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making it the first ...
The San Joaquin County Mosquito and Vector Control District will not increase its benefit assessment rates for the 2026-27 fiscal year. The district's Board of Trustees ...
Victoria Ingham discusses the importance of insecticides in controlling vector-borne diseases and the ReMVeC project, which ...
New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...
SAEHP has announced that the British Government has confirmed a decision permitting the direct import of live horses from South Africa.
President Donald Trump’s approval rating has dropped to a new low in a recent American Research Group poll, with just 30% of Americans approving of his job performance as the 2026 midterm elections ...
Viral cell and gene therapies (CGT) have transformed modern medicine by offering durable, and in some instances curable, solutions for rare and previously untreatable diseases. Although only 24 viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results